Pure Global
NCT06398912

Studying Newborns' Brain Activity in the NICU Through a Musical Intervention: the Role of Fundamental Frequency

Oslo Metropolitan University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Premature Birth
Drug/Device/Intervention
Music Based Intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Oslo Metropolitan University
Location
Athens, Greece
Timeline & enrollment
Phase
N/A
Start date
Apr 20, 2023
End date
Jan 01, 2026
Enrollment
30 participants
Primary outcome

qEEG features changes before, during and after the delivery of the musical intervention correlated to the fundamental frequency of the signing voice of the music facilitators

Summary

This research project stands to the intersection of neonatology, neuroscience, and music
 based interventions (MBIs), exploring the impact of structured sound on the brain activity of
 premature newborns in Neonatal Intensive Care Units (NICU). It embarks on a pioneering
 investigation to decipher how variations in musical stimuli, particularly those that differ
 in human profiles (gender and kinship) and fundamental frequencies, affect the short-term
 electroencephalographic (EEG) footprint of these vulnerable infants. The project aims to
 uncover profound insights into the therapeutic potential of music within neonatal care,
 thereby advancing our understanding of neurodevelopmental interventions for premature
 infants.

ICD-10 classifications
Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06398912
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06398912 through Pure Global AI's free database. This phase not specified trial is sponsored by Oslo Metropolitan University and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.